Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial.
British journal of cancer.
Times cited: 40
Improved survival with ipilimumab in patients with metastatic melanoma.
The New England journal of medicine.
Times cited: 5228